Recent research on MCL-1, a critical protein that is an attractive target for cancer drug development, helps explain why some ...

Rentosertib, an AI-generated small molecule targeting Traf2- and Nck-interacting kinase, was safe and improved FVC in ...

Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are ...

The acquisition will expand AbbVie's exploration of in vivo CAR-T therapy, an ambitious approach that could sidestep some of ...

FDA's plan to phase out animal testing may hurt Charles River's revenues. The DCF model suggests that CRL presents an ...

Proteins have specific biological functions in cells through conformational changes and interactions. Therefore, precise, in ...

AbbVie gains control of an in vivo CAR-T therapy that could overcome limitations with currently approved autologous ...

DIADEME’ project awarded €6.5 million in government funding via France 2030, enabling Ciloa to advance development of its bio-drug APN-sEV (Adiponectin associated with exosomes), the world’s only ...

The entire process can take weeks, though many companies are working on ways to make it faster and more efficient. In vivo engineering of a patient’s immune cells would avoid this expensive ...

Instead of extracting T-cells and engineering them in a lab, researchers have delivered mRNA directly into circulating immune ...

CN Bio introduces cross-species DILI services to enhance in vitro to in vivo extrapolationduring preclinical drug development. Extends capabilities of industry-leading PhysioMimix DILI assay for ...

WASHINGTON (TNND) — The Food and Drug Administration has announced some major changes to the review process for drug developers in the United States. It could cut down the time from 10-12 months ...